Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway

Fig. 4

Antitumor immune response elicited by the combination therapy. a Serum Trp/Kyn ratios, measured by LC/MS. Blood samples were taken from animals 1 day after the treatments. b, c Lymphocyte frequencies in tumor (c) and spleen (d). Tissues were harvested 7 days after the third treatment. d CD8/Treg ratios in tumor (left) and spleen (right) tissues. Values are presented as means ± SD. *p < 0.05, **p < 0.01

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us